
Shares of telehealth firm Doximity DOCS.N slump 14.7% to $49.84 after co's forecast misses expectations
Co forecasts FY26 revenue between $619 mln and $631 mln vs analysts' estimate of $635 mln - data compiled by LSEG
Midpoint of Q1 revenue outlook also below estimate
At least four brokerages cut PT, including Truist Securities
Piper Sandler lowers PT but says they "would buy this morning's weakness" as co's top-line growth forecast is appropriate due to uncertain impact of policy
Eight out of 20 analysts rate stock as "buy" or higher, 12 "hold"; median PT is $70
Including session's moves, DOCS down 5.6% YTD